October 11, 2024
PacBio to Report Third Quarter 2024 Financial Results on November 7, 2024
MENLO PARK, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) announced today that it will hold its quarterly…
Pharmaceuticals, Biotechnology and Life Sciences
MENLO PARK, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) announced today that it will hold its quarterly…
Portfolio expansion reinforces QIAGEN’s leadership in automated solutions for non-invasive liquid biopsy applications combined with complete workflows // New ccfDNA…
NEW YORK, Oct. 10, 2024 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a…
Senseonics’ Eversense 365 is approved in the US as an integrated continuous glucose monitoring (iCGM) system for people with Type…
High DAR Dual-Payload ADC Sutro unveils unique cell-free capabilities Proprietary cell-free platform enables the design of next-generation ADCs intended to…
Press Release €451M Revolving Credit Facility refinanced with a maturity extended to February 2029Issuance of a €200M Perpetual Deeply Subordinated…
Listing market: Euronext Paris (Market segment C – ISIN Code: FR001400K4B1- Symbol: PHXM) Website : www.phaxiam.com DateTotal of shares composing the…
NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) — Guggenheim Securities, LLC is issuing a statement on behalf of former Pfizer…
Strategic Agreements Unite Companies to Enhance Operational Synergies in the California Cannabis MarketSALINAS, Calif., Oct. 09, 2024 (GLOBE NEWSWIRE) —…
LOS ANGELES, Oct. 09, 2024 (GLOBE NEWSWIRE) — Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, announced today…